• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

范式的风险:复杂性、政策设计与内分泌干扰物筛查计划

Perils of paradigm: complexity, policy design, and the Endocrine Disruptor Screening Program.

作者信息

Vogel Jason M

机构信息

Environmental Studies Program, University of Colorado, Campus Box 397, Boulder, CO 80309-0397, USA.

出版信息

Environ Health. 2005 Feb 8;4(1):2. doi: 10.1186/1476-069X-4-2.

DOI:10.1186/1476-069X-4-2
PMID:15701170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC549529/
Abstract

The Endocrine Disruptor Screening Program (EDSP), mandated by the United States Congress in the Food Quality Protection Act of 1996, attempts to protect public health from adverse endocrine effects of synthetic chemical compounds by establishing a new testing regime. But the complexities and uncertainties of endocrine disruption and its broader regulatory and social context all but ensure the failure of this policy. This article addresses the issues facing EDSP comprehensively and in detail, in order to move beyond the current regulatory paradigm and foster discourse on a positive role for scientists in support of EDSP's end goal: to protect public health.

摘要

1996年美国国会在《食品质量保护法》中授权实施的内分泌干扰物筛查计划(EDSP),试图通过建立一种新的检测制度来保护公众健康免受合成化学化合物的不良内分泌影响。但是,内分泌干扰的复杂性和不确定性及其更广泛的监管和社会背景几乎注定了这项政策的失败。本文全面而详细地探讨了EDSP面临的问题,以便超越当前的监管模式,并促进关于科学家在支持EDSP最终目标(保护公众健康)方面的积极作用的讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb1/549529/a7e110a894bf/1476-069X-4-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb1/549529/46d2ad75f0cb/1476-069X-4-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb1/549529/a7e110a894bf/1476-069X-4-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb1/549529/46d2ad75f0cb/1476-069X-4-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb1/549529/a7e110a894bf/1476-069X-4-2-2.jpg

相似文献

1
Perils of paradigm: complexity, policy design, and the Endocrine Disruptor Screening Program.范式的风险:复杂性、政策设计与内分泌干扰物筛查计划
Environ Health. 2005 Feb 8;4(1):2. doi: 10.1186/1476-069X-4-2.
2
Uncertainties for endocrine disrupters: our view on progress.内分泌干扰物的不确定性:我们对进展的看法。
Toxicol Sci. 2003 Aug;74(2):245-52. doi: 10.1093/toxsci/kfg105. Epub 2003 May 2.
3
Updating the Toxic Substances Control Act to Protect Human Health.更新《有毒物质控制法》以保护人类健康。
JAMA. 2016 Apr 19;315(15):1565-6. doi: 10.1001/jama.2016.2037.
4
Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies.为内分泌干扰物研究和测试选择合适的动物模型和实验设计。
ILAR J. 2004;45(4):387-93. doi: 10.1093/ilar.45.4.387.
5
Why the toxic substances control act needs an overhaul, and how to strengthen oversight of chemicals in the interim.为什么《有毒物质控制法》需要全面修订,以及如何在过渡期间加强对化学品的监督。
Health Aff (Millwood). 2011 May;30(5):898-905. doi: 10.1377/hlthaff.2011.0211.
6
Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.不良结局途径在美国环境保护局内分泌干扰物筛选计划中的应用。
Environ Health Perspect. 2017 Sep 1;125(9):096001. doi: 10.1289/EHP1304.
7
The promise of exposure science.暴露科学的前景。
J Expo Sci Environ Epidemiol. 2011 Mar-Apr;21(2):121-2. doi: 10.1038/jes.2010.55. Epub 2011 Jan 12.
8
Use of the laboratory rat as a model in endocrine disruptor screening and testing.将实验大鼠用作内分泌干扰物筛选和测试的模型。
ILAR J. 2004;45(4):425-37. doi: 10.1093/ilar.45.4.425.
9
Endocrine modulators: risk characterization and assessment.内分泌调节剂:风险特征描述与评估
Toxicol Pathol. 2000 May-Jun;28(3):438-40. doi: 10.1177/019262330002800313.
10
Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program.经验教训、挑战和机遇:美国内分泌干扰物筛查计划。
ALTEX. 2014;31(1):63-78. doi: 10.14573/altex.1309171. Epub 2013 Oct 10.

引用本文的文献

1
Impact of perinatal environmental health education intervention on exposure to endocrine disruptors during pregnancy-PREVED study: study protocol for a randomized controlled trial.围产期环境健康教育培训干预对孕妇接触内分泌干扰物影响的研究(PREVED 研究):一项随机对照试验的研究方案。
Trials. 2021 Dec 4;22(1):876. doi: 10.1186/s13063-021-05813-5.
2
Environmental Health Knowledge, Attitudes, and Practices of French Prenatal Professionals Working with a Socially Underprivileged Population: A Qualitative Study.环境健康知识、态度和实践:为社会弱势群体服务的法国产前专业人员的定性研究。
Int J Environ Res Public Health. 2019 Jul 16;16(14):2544. doi: 10.3390/ijerph16142544.
3

本文引用的文献

1
Hormesis. Sipping from a poisoned chalice.毒物兴奋效应。从有毒圣杯中啜饮。
Science. 2003 Oct 17;302(5644):376-9. doi: 10.1126/science.302.5644.376.
2
A new approach to risk evaluation and management: risk-based, precaution-based, and discourse-based strategies.一种风险评估与管理的新方法:基于风险、基于预防和基于话语的策略。
Risk Anal. 2002 Dec;22(6):1071-94. doi: 10.1111/1539-6924.00274.
3
Developmental toxicity of a commercial herbicide mixture in mice: I. Effects on embryo implantation and litter size.一种商用除草剂混合物对小鼠的发育毒性:I. 对胚胎着床和窝仔数的影响。
Trends in reproductive health in Israel: implications for environmental health policy.
以色列生殖健康趋势:对环境健康政策的启示。
Isr J Health Policy Res. 2012 Aug 28;1(1):34. doi: 10.1186/2045-4015-1-34.
Environ Health Perspect. 2002 Nov;110(11):1081-5. doi: 10.1289/ehp.021101081.
4
Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling.基于生理药代动力学/药效学(PBPK/PD)和定量构效关系(QSAR)建模开发替代和预测毒理学的方法。
Environ Health Perspect. 1998 Dec;106 Suppl 6(Suppl 6):1385-93. doi: 10.1289/ehp.98106s61385.
5
A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues.非霍奇金淋巴瘤与血清有机氯残留的巢式病例对照研究。
Lancet. 1997 Jul 26;350(9073):240-4. doi: 10.1016/S0140-6736(97)02088-6.
6
Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses.小鼠因在胎儿期接触低剂量雌二醇或己烯雌酚而出现前列腺肿大,而高剂量时则产生相反的效果。
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2056-61. doi: 10.1073/pnas.94.5.2056.
7
Nutrition and lead: strategies for public health.营养与铅:公共卫生策略
Environ Health Perspect. 1995 Sep;103 Suppl 6(Suppl 6):191-6. doi: 10.1289/ehp.95103s6191.